TY  - GEN 
AU  - Adan, A.
AU  - Cabrera, F.
AU  - Figueroa, M. S.
AU  - Cervera, E.
AU  - Ascaso, F. J.
AU  - Udaondo, P.
AU  - Abraldes Lopez-Veiga, Maximino
AU  - Reyes, M. A.
AU  - Pazos, M.
AU  - Pessoa, B.
AU  - Armada, F.
PY  - 2020
SN  - 1177-5467
UR  - http://hdl.handle.net/20.500.11940/16584
AB  - Current management of diabetic macular edema (DME) predominantly involves treatment with short-acting intravitreal injections of anti-vascular endothelial growth factors (anti-VEGFs) and/or corticosteroids; however, short-acting therapies (lasting...
TI  - Clinical-Decision Criteria to Identify Recurrent Diabetic Macular Edema Patients Suitable for Fluocinolone Acetonide Implant Therapy (ILUVIEN (R)) and Follow-Up Considerations/Recommendations
DO  - 10.2147/opth.s252359
KW  - CHUS
VL  - 14.
ER  -